PCM
TEVA icon

Poehling Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Poehling Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Buy
+6,499
New +$216K 0.05% 154
2018
Q3 		– Sell
-2,500
Closed -$61K – 240
2018
Q2 		$61K Hold
2,500
– – 0.05% 135
2018
Q1 		$43K Hold
2,500
– – 0.03% 158
2017
Q4 		$47K Buy
+2,500
New +$37.6K 0.04% 150

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Poehling Capital Management's TEVA Position: Q2 2026 in Review

Poehling Capital Management opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 6,499 shares worth $220K. The stake represents 0.05% of the portfolio and ranks #154 among its holdings. This is a return to the name: Poehling Capital Management previously reported a position in TEVA as recently as Q2 2018.

Poehling Capital Management first reported a position in TEVA in Q4 2017 and has held it in 4 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Poehling Capital Management held 6,499 shares of Teva Pharmaceutical Industries Limited worth $220K as of Q2 2026.
  • Teva Pharmaceutical Industries Limited was a new Poehling Capital Management position in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up 0.05% of Poehling Capital Management's portfolio in Q2 2026, its #154 holding.
  • Poehling Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2017 and has held it in 4 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Poehling Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.